Dilated cardiomyopathy (DCM) is a disease of the heart muscle that is characterized by ventricular dilatation and impaired systolic function. The 5-year survival after the diagnosis of DCM is 50%, and the prediction of death in patients with DCM is still challenging [1, 2] . QRS prolongation on the electrocardiogram (ECG) represents an intraventricular conduction delay. Recent studies have indicated that QRS prolongation was a predictor of mortality and arrhythmias in heart failure and DCM [3] [4] [5] . Accordingly, the aim of this present study was to assess the association between QRS prolongation and mortality in a large sample of DCM patients.
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An observational cohort study of 1317 DCM hospitalized patients was conducted from November 2003 to September 2011 in Fuwai Hospital. DCM was defined as systolic dysfunction with left ventricle (LV) dilation in the absence of an apparent secondary cause of cardiomyopathy [6] . Of the 1317 enrolled patients, 23 patients with missed electrocardiograph test results and 175 patients were excluded from the study with patients who had various secondary cardiomyopathies. Thus, the final analysis included 1119 patients. The primary end point of the study was all-cause mortality, which was assessed for all patients by medical records and medical follow-up calls. The mean follow-up period was 3.5 ± 2.3 years, and the study protocol was approved by the Ethics Commission of Fuwai Hospital.
Continuous variables are expressed as the mean ± SD or medians and interquartile ranges. Comparisons of categorical variables among groups were conducted using Chi-square tests. ANOVA was used for the comparison of means from multiple groups. Kaplan-Meier survival curves were compared using the log-rank test. Cox proportional hazard modeling was used to examine the associations between independent factors and survival with adjustments for potential confounders. The analyses were conducted with SPSS and a P value b 0.05 was used to determine statistical significance.
The cohort consisted of 1119 patients with DCM (age: 51.1 ± 14.7 years, male: 73.4%), 19.3% (n = 216) had QRS N 150 ms, 23.0% (n = 257) had QRS = 120-150 ms, and 57.7% (n = 646) had QRS b 120 ms. Compared with the QRS b 120 ms patients, the QRS N 150 ms patients were older and more with females, longer disease duration, larger LV diameter, and lower LV ejection fraction (LVEF) value; QRS = 120-150 ms patients had larger left atrium (LA) diameter, and less usage of beta-blockers, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers (Table 1) .
During the mean follow-up of 3.5 ± 2.3 years, 268 (23.9%) died. Of those, the all-cause mortality rates were highest in the patients with QRS N 150 ms (n = 72, 33.3%), intermediate in those with QRS =120-150 ms (n = 85, 33.1%), and lowest in those with QRS b 120 ms (n = 111, 17.2%), showing a significant difference in the all-cause morbidity risk among the QRS duration groups (log-rank χ 2 = 42.811, P b 0.001, Fig. 1 ).
Univariate analysis indicated that age, history of atrial fibrillation (AF), NYHA functional classes, disease duration, systolic blood pressure, diastolic blood pressure, LV, LA, right ventricle (RV) diameters, LVEF, and QRS duration, were the predictors of all-cause mortality in DCM patients. After adjustment for age, sex, history of diabetes mellitus and AF, smoking and drinking status, disease duration, heart rate, blood pressure, LVEF, LV and RV diameter, the Cox multivariate analysis showed that the QRS duration, LA diameter and NYHA functional class were the independent predictors of all-cause mortality.
QRS prolongation is well-known to occur in the general population, increasing sharply with age [7] . QRS duration is also reported to correlate with cardiac size, LV dilatation, and systolic dysfunction [7, 8] and an increased QRS duration was a risk factor for arrhythmic deaths and all-cause mortality in post-myocardial infarction patients [9, 10] . Recent studies have suggested that a prolonged QRS duration is a risk factor for International Journal of Cardiology 172 (2014) e475-e477 mortality in patients with heart failure and DCM [3] [4] [5] . In our study, the patients with QRS ≥ 120 ms had a higher all-cause mortality rate than those with QRS b 120 ms and that QRS duration was a strong predictor of all-cause mortality in patients with DCM even after adjustment for the classic risk factors. However, we did not find a difference in the all-cause mortality rate between patients with QRS N 150 ms and patients with QRS = 120-150 ms. In conclusion, the prolongation of the QRS duration at admission is a predictor of mortality in patients with DCM. 1. Data are expressed as mean ± SD or median (interquartile range) or as percentages, P values from an ANOVA for all three groups. 2. Thirty-four patients lacked echocardiography data, 341 patients lacked NT-pro-BNP levels, 52 patients lacked fasting blood glucose levels, 46 patients lacked creatinine, BUN levels. 3. Abbreviations: NYHA, New York Heart Association; SBP, systolic blood pressure; DBP, diastolic blood pressure; BUN, blood urea nitrogen; NT-pro-BNP, N-terminal fragment pro-brain natriuretic peptide; LV, left ventricle; LA, left atrium; LVEF, left ventricular ejection fraction; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker. 
